Tag:

Immunocompromised Individuals

Vicious Norovirus Strain Driving Surge In US Outbreaks: What To Know Vicious Norovirus Strain Driving Surge In US Outbreaks: What To Know
Vicious Norovirus Strain Driving Surge In US Outbreaks: What To Know A highly contagious strain of norovirus, GII.17, is rapidly spreading across the United States, fueling an unusually high number of outbreaks, according to the Centers for Disease Control and Prevention (CDC). Key Facts Record Outbreaks: The CDC reported 91 suspected or confirmed norovirus outbreaks in the first week of December, the highest for this time of year in recent history. Dominant Strain: GII.17 accounts for nearly 70 percent of US cases and has driven a similar surge in Britain. Foodborne Threats: Contaminated oysters from a Los Angeles event sickened at least 80 people. Recall…
Nationwide Recall Issued For Brand Of Eye Drops Over Contamination Risk Nationwide Recall Issued For Brand Of Eye Drops Over Contamination Risk
Nationwide Recall Issued For Brand Of Eye Drops Over Contamination Risk A nationwide recall has been issued for a specific lot of eye drops due to potential fungal contamination, which could cause serious eye infections. The recall involves lubricant eye drops under the Systane brand, manufactured by Alcon Laboratories, following a report of fungal material found in a sealed vial.  No illnesses have been reported, but fungal contamination can pose vision-threatening risks and, in rare cases, life-threatening complications for immunocompromised individuals. Details of the recall: Specific brand: Systane Lubricant Eye Drops Ultra PF, Single Vials On-…
COVID-19: Health Department Urges NYers To Get Vaccine As Respiratory Illness Season Starts COVID-19: Health Department Urges NYers To Get Vaccine As Respiratory Illness Season Starts
Covid-19: Health Department Urges NYers To Get Vaccine As Respiratory Illness Season Starts With respiratory illness season underway, the New York State Department of Health is actively urging residents aged 6 months and older to get the latest COVID-19 vaccine.  This recommendation aligns with the Centers for Disease Control and Prevention (CDC) recent update, which emphasizes the importance of a second dose of the 2024-2025 vaccine for older adults and those at higher risk. The CDC now advises that adults aged 65 and older, along with individuals who are moderately or severely immunocompromised, should receive a second dose six months after their initial vaccination. This u…